Athanasios Skarpelos
Director at Anavex Life Sciences Corp. (AVXL)
Athanasios Skarpelos has filed 6 insider reports with the SEC since August 2021, as director at Anavex Life Sciences Corp. (AVXL). Athanasios Skarpelos made no open-market purchases or sales in the last 12 months. The latest filing, on April 3, 2025, reports grant or award at Anavex Life Sciences Corp. (AVXL).
- Filings
- 6
- Companies
- 1
- Bought on market
- None
- Sold on market
- $453K
Companies where Athanasios Skarpelos is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 1,306,458 | $453K | $0.6675 | Apr 3, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 31, 2025AVXLSEC Form 4 filed by Director Skarpelos AthanasiosForm 4Grant or award
- Feb 20, 2024AVXLSEC Form 4 filed by Skarpelos AthanasiosForm 4Grant or award
- Mar 31, 2023AVXLSEC Form 4 filed by Skarpelos AthanasiosForm 4Grant or award
- Jun 27, 2022AVXLSEC Form 4 filed by Skarpelos AthanasiosForm 4Grant or award
- May 25, 2022-$453KAVXLSEC Form 4: Skarpelos Athanasios exercised 50,000 shares at a strike of $0.92 and sold $453,000 worth of shares (50,000 units at $9.06)Form 4Exercise or conversion of a derivativeOpen-market sale
- Aug 2, 2021AVXLSEC Form 4 filed by Skarpelos AthanasiosForm 4Grant or award
Compare Athanasios Skarpelos with
- Athanasios Skarpelos vs Claus Vander Velden1 shared
- Athanasios Skarpelos vs Peter D.O. Donhauser1 shared
- Athanasios Skarpelos vs Terrie Kellmeyer1 shared
- Athanasios Skarpelos vs Axel Paeger1 shared
- Athanasios Skarpelos vs Sandra Boenisch1 shared
- Athanasios Skarpelos vs Christopher U Missling1 shared
Other insiders at the same companies
- Claus Vander VeldenAVXL
- Peter D.O. DonhauserAVXL
- Terrie KellmeyerAVXL
- Axel PaegerAVXL
- Sandra BoenischAVXL
- Christopher U MisslingAVXL
- Steffen ThomasAVXL
- Jiong MaAVXL
Questions about Athanasios Skarpelos
- What is Athanasios Skarpelos's role at Anavex Life Sciences Corp.?
- Athanasios Skarpelos reports to the SEC as director at Anavex Life Sciences Corp. (AVXL), according to the latest filing on April 3, 2025.
- How many shares does Athanasios Skarpelos own?
- After the latest filing that states it, Athanasios Skarpelos directly owned 1,306,458 shares of Anavex Life Sciences Corp. (AVXL). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Athanasios Skarpelos bought or sold stock recently?
- The most recent open-market sale was on May 25, 2022: sold 50,000 shares of Anavex Life Sciences Corp. (AVXL) for $453K at an average of $9.06.
- How do I get alerts when Athanasios Skarpelos files?
- Follow Athanasios Skarpelos on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Athanasios Skarpelos (SEC CIK 0001360570). Totals count each trade once, skipping amendments whose original is on file, from Aug 4, 2021 on. View on SEC EDGAR · Get this as JSON